The author's undisclosed TradingView strategy, applied to ES futures, generated a positive equity curve in a ~3.5 month backtest. If the strategy's logic is sound and not overfitted, it implies a systematic edge in trading the S&P 500 index, which can be monitored via SPY. The post presents an unvalidated but apparently successful short-term systematic approach to the S&P 500, warranting caution and further investigation rather than immediate action. Extreme overfitting to a very short data sample; lack of any strategy details (entries, exits, stops); no live trading verification; performance likely not accounting for realistic slippage and commissions. No other actionable trade ideas in this post.
SPY
MED
Apr 14, 18:47
Key Points
['Backtest only ~3.5 months', 'No strategy logic disclosed', 'High overfitting risk', 'ES futures -> SPY proxy', 'Seek validation first']
April 14, 2026 at 18:47